Anti-Neoplastics | ACGHolmes

top of page

ACG

h.o.l.M.E.S.

Automated Clinical Guidelines

Anti-Neoplastics

Alkylating Agents

Anti-CTLA-4 Monoclonal Antibodies

Anti-PD-1 Monoclonal Antibodies

Antibiotics/Antineoplastics

Antimetabolites

Antineoplastic Combinations

Antineoplastic Detoxifying Agents

Antineoplastic Interferons

BCR-ABL Tyrosine Kinase Inhibitors

Bruton Tyrosine Kinase (BTK) Inhibitors

CD20 Monoclonal Antibodies

CD30 Monoclonal Antibodies

CD33 Monoclonal Antibodies

CD38 Monoclonal Antibodies

CD52 Monoclonal Antibodies

cdk-4-6 inhibitors.jpg

CDK 4/6 inhibitors

EGFR inhibitors

Hedgehog Pathway Inhibitors

HER2 Inhibitors

Histone Deacetylase Inhibitors

Hormones/Antineoplastics

Malignancy Photosensitizers

Miscellaneous Antineoplastics

Mitotic Inhibitors

mTOR Inhibitors

Multikinase Inhibitors

PARP Inhibitors

PI3K Inhibitors

Proteasome Inhibitors

VEGF/VEGFR Inhibitors

bottom of page